Skip to main content
SpringerLink
Log in

Sirt1 inhibits gouty arthritis via activating PPARγ

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Objective

To identify the effects of Sirtuin 1 (Sirt1) on gouty arthritis and investigate the underlying mechanisms.

Methods

A gouty arthritis model was established by intra-articular injection of monosodium urate (MSU, 1 mg) crystal solution into the left foot pad of C57BL/6 mice. After pretreating the gouty arthritis mice with intra-articular injection of Sirt1 agonist (Resveratrol, RSV, 20 mg/kg) or peroxisome proliferator-activated receptor γ (PPARγ) inhibitor (T0070907, 1 mg/kg), the degree of joint inflammation of the gouty arthritis mice was evaluated by clinical integration of joint inflammation and hematoxylin and eosin (H&E) staining. The mRNA expression of Sirt1 and PPARγ were determined by real-time polymerase chain reaction (PCR). The expression profiling of inflammatory cytokines and chemokines in mouse joint tissues were determined by multi-factor assay kits. Peritoneal macrophages were isolated from mice and tested the effects of RSV and/or PPARγ on pro-inflammatory cytokines secretion by PCR.

Results

Sirt1 agonist significantly suppressed the onset of gouty arthritis induced by MSU and reduced the infiltration of inflammatory cells in the joints. Sirt1 agonist significantly promoted the expression of PPARγ, while decreased the expression of interleukin (IL)-1β, IL-1α, IL-6, interferon-γ (IFN-γ), monocyte chemotactic protein 1(MCP-1), tumor necrosis factor a (TNF-α), and chemokines (CXCL-1, CXCL-5, CCL-22) induced by MSU in joint tissues. After blocking PPARγ with T0070907 or by siRNA, the anti-inflammatory effect of Sirt1 agonist on gouty arthritis disappeared and the expression of pro-inflammatory molecules were not significantly reduced.

Conclusions

Sirt1 may control the acute onset of gouty arthritis in mice by inhibiting the infiltration of inflammatory cells and the secretion of pro-inflammatory molecules through PPARγ.

Key Points

• Sirt1 and its activator, RSV, attenuate the severity of gouty arthritis in mice.

• Sirt1 inhibits the infiltration of inflammatory cells and the secretion of pro-inflammatory molecules in MSU-induced arthritis.

• Sirt1 inhibits inflammation partially dependent on PPARγ.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Schumacher HR (1996) Crystal-induced arthritis: an overview. Am J Med 100(2A):46S–52S

    Article  CAS  Google Scholar 

  2. Di Giovine FS, Malawista SE, Nuki G, Duff GW (1987) Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol 138(10):3213–3218

    PubMed  Google Scholar 

  3. Guerne PA, Terkeltaub R, Zuraw B, Lotz M (1989) Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 32(11):1443–1452

    Article  CAS  Google Scholar 

  4. Matsukawa A, Yoshimura T, Maeda T, Takahashi T, Ohkawara S, Yoshinaga M (1998) Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis. Lab Investig 78(5):559–569

    CAS  PubMed  Google Scholar 

  5. di Giovine FS, Malawista SE, Thornton E, Duff GW (1991) Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest 87(4):1375–1381. https://doi.org/10.1172/JCI115142

    Article  PubMed  PubMed Central  Google Scholar 

  6. Wang J, Zhu XX, Liu L, Xue Y, Yang X, Zou HJ (2016) SIRT1 prevents hyperuricemia via the PGC-1alpha/PPARgamma-ABCG2 pathway. Endocrine 53(2):443–452. https://doi.org/10.1007/s12020-016-0896-7

    Article  CAS  PubMed  Google Scholar 

  7. Chen H, Zheng S, Wang Y, Zhu H, Liu Q, Xue Y, Qiu J, Zou H, Zhu X (2014) The effect of resveratrol on the recurrent attacks of gouty arthritis. Clin Rheumatol. https://doi.org/10.1007/s10067-014-2826-5

  8. Borra MT, Smith BC, Denu JM (2005) Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 280(17):17187–17195. https://doi.org/10.1074/jbc.M501250200

    Article  CAS  PubMed  Google Scholar 

  9. Knight JR, Milner J (2012) SIRT1, metabolism and cancer. Curr Opin Oncol 24(1):68–75. https://doi.org/10.1097/CCO.0b013e32834d813b

    Article  CAS  PubMed  Google Scholar 

  10. Pham J, Arul Nambi Rajan K, Li P, Parast MM (2018) The role of Sirtuin1-PPARgamma axis in placental development and function. J Mol Endocrinol 60(4):R201–R212. https://doi.org/10.1530/JME-17-0315

    Article  CAS  PubMed  Google Scholar 

  11. Engler A, Tange C, Frank-Bertoncelj M, Gay RE, Gay S, Ospelt C (2016) Regulation and function of SIRT1 in rheumatoid arthritis synovial fibroblasts. J Mol Med (Berl) 94(2):173–182. https://doi.org/10.1007/s00109-015-1332-9

    Article  CAS  Google Scholar 

  12. Siebert A, Goren I, Pfeilschifter J, Frank S (2016) Anti-inflammatory effects of rosiglitazone in obesity-impaired wound healing depend on adipocyte differentiation. PLoS One 11(12):e0168562. https://doi.org/10.1371/journal.pone.0168562

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Denko CW, Whitehouse MW (1976) Experimental inflammation induced by naturally occurring microcrystalline calcium salts. J Rheumatol 3(1):54–62

    CAS  PubMed  Google Scholar 

  14. Martin WJ, Walton M, Harper J (2009) Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout. Arthritis Rheum 60(1):281–289. https://doi.org/10.1002/art.24185

    Article  PubMed  Google Scholar 

  15. Orlowsky EW, Stabler TV, Montell E, Verges J, Kraus VB (2014) Monosodium urate crystal induced macrophage inflammation is attenuated by chondroitin sulphate: pre-clinical model for gout prophylaxis? BMC Musculoskelet Disord 15:318. https://doi.org/10.1186/1471-2474-15-318

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23(12):2369–2380. https://doi.org/10.1038/sj.emboj.7600244

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A (2013) Antagonistic crosstalk between NF-kappaB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal 25(10):1939–1948. https://doi.org/10.1016/j.cellsig.2013.06.007

    Article  CAS  PubMed  Google Scholar 

  18. Akahoshi T, Namai R, Murakami Y, Watanabe M, Matsui T, Nishimura A, Kitasato H, Kameya T, Kondo H (2003) Rapid induction of peroxisome proliferator-activated receptor gamma expression in human monocytes by monosodium urate monohydrate crystals. Arthritis Rheum 48(1):231–239. https://doi.org/10.1002/art.10709

    Article  CAS  PubMed  Google Scholar 

  19. Calleri E, Pochetti G, Dossou KSS, Laghezza A, Montanari R, Capelli D, Prada E, Loiodice F, Massolini G, Bernier M, Moaddel R (2014) Resveratrol and its metabolites bind to PPARs. Chembiochem 15(8):1154–1160. https://doi.org/10.1002/cbic.201300754

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado De Oliveira R, Leid M, McBurney MW, Guarente L (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429(6993):771–776. https://doi.org/10.1038/nature02583

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Qiang L, Wang L, Kon N, Zhao W, Lee S, Zhang Y, Rosenbaum M, Zhao Y, Gu W, Farmer SR, Accili D (2012) Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Ppargamma. Cell 150(3):620–632. https://doi.org/10.1016/j.cell.2012.06.027

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Han L, Zhou R, Niu J, McNutt MA, Wang P, Tong T (2010) SIRT1 is regulated by a PPAR{gamma}-SIRT1 negative feedback loop associated with senescence. Nucleic Acids Res 38(21):7458–7471. https://doi.org/10.1093/nar/gkq609

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Lee MF, Liou TH, Wang W, Pan WH, Lee WJ, Hsu CT, Wu SF, Chen HH (2013) Gender, body mass index, and PPARgamma polymorphism are good indicators in hyperuricemia prediction for Han Chinese. Genet Test Mol Biomarkers 17(1):40–46. https://doi.org/10.1089/gtmb.2012.0231

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Ruiz-Miyazawa KW, Staurengo-Ferrari L, Pinho-Ribeiro FA, Fattori V, Zaninelli TH, Badaro-Garcia S, Borghi SM, Andrade KC, Clemente-Napimoga JT, Alves-Filho JC, Cunha TM, Fraceto LF, Cunha FQ, Napimoga MH, Casagrande R, Verri WA Jr (2018) 15d-PGJ2-loaded nanocapsules ameliorate experimental gout arthritis by reducing pain and inflammation in a PPAR-gamma-sensitive manner in mice. Sci Rep 8(1):13979. https://doi.org/10.1038/s41598-018-32334-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, Santoro MG (2000) Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403(6765):103–108. https://doi.org/10.1038/47520

    Article  CAS  PubMed  Google Scholar 

  26. Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G, Glass CK (2000) 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci U S A 97(9):4844–4849

    Article  CAS  Google Scholar 

  27. Tani Y, Isobe Y, Imoto Y, Segi-Nishida E, Sugimoto Y, Arai H, Arita M (2014) Eosinophils control the resolution of inflammation and draining lymph node hypertrophy through the proresolving mediators and CXCL13 pathway in mice. FASEB J 28(9):4036–4043. https://doi.org/10.1096/fj.14-251132

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

    Juan Wang & Liangjing Lu

  2. Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China

    Guangliang Chen

  3. Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong-An Rd, Shanghai, 200032, China

    Guangliang Chen

  4. Division of Rheumatology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China

    Hejian Zou

  5. Institute of Rheumatology, Immunology and Allergy, Huashan Hospital, Shanghai Medical College, Fudan University, No. 12, Middle Wulumuqi Road, Shanghai, 200040, China

    Hejian Zou

Authors
  1. Juan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guangliang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Liangjing Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hejian Zou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Liangjing Lu or Hejian Zou.

Ethics declarations

All the animal procedures were approved by the ethics committee of the Animal Experiments Committee of Shanghai Jiao Tong University.

Disclosures

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Juan Wang and Guangliang Chen are co-first authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, J., Chen, G., Lu, L. et al. Sirt1 inhibits gouty arthritis via activating PPARγ. Clin Rheumatol 38, 3235–3242 (2019). https://doi.org/10.1007/s10067-019-04697-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-019-04697-w

Keywords

Search

Navigation